Inogen (INGN) Scheduled to Post Quarterly Earnings on Thursday

Inogen (NASDAQ:INGN - Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Inogen has set its FY 2024 guidance at EPS.Individual that are interested in registering for the company's earnings conference call can do so using this link.

Inogen (NASDAQ:INGN - Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The medical technology company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.55) by $0.31. The firm had revenue of $88.77 million for the quarter, compared to analyst estimates of $82.50 million. Inogen had a negative return on equity of 45.37% and a negative net margin of 28.30%. The business's revenue was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.42) EPS. On average, analysts expect Inogen to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Inogen Trading Down 5.8 %

NASDAQ:INGN traded down $0.54 on Thursday, reaching $8.73. 274,416 shares of the stock traded hands, compared to its average volume of 335,948. Inogen has a 1-year low of $4.37 and a 1-year high of $13.33. The company's 50 day moving average is $10.40 and its 200-day moving average is $9.29. The firm has a market capitalization of $205.83 million, a price-to-earnings ratio of -2.09 and a beta of 1.04.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Needham & Company LLC restated a "hold" rating on shares of Inogen in a report on Wednesday, August 7th. StockNews.com raised Inogen from a "sell" rating to a "hold" rating in a research note on Tuesday, August 13th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $7.00.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.